Internal Medicine, Infectious Disease · Cleveland, OH
NPI
1881614576
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
11100 Euclid Ave
Cleveland, OH, 44106
Phone (216) 844-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
272 services
Medicare patients, 2024
128
Average age 69
Drug cost, 2024
$2.1M
1,783 prescriptions
Company payments, 2025
$366
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle V Lisgaris was code 99232 (hospital e&m - subsequent), 62 times for 41 patients. In total Michelle V Lisgaris billed 272 services in 20 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 62 | 41 | $59.69 | $3,701 |
| 99222 Hospital E&M - Initial | Facility | 34 | 32 | $99.05 | $3,368 |
| 99233 Hospital E&M - Subsequent | Facility | 33 | 25 | $89.98 | $2,969 |
| 99215 Office E&M - Established | Office | 21 | 21 | $136.45 | $2,866 |
| 99231 Hospital E&M - Subsequent | Facility | 21 | 18 | $37.52 | $788 |
| 99221 Hospital E&M - Initial | Facility | 14 | 14 | $62.86 | $880 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $131.64 | $1,580 |
By year: 2022 $26K for 365 services; 2023 $21K for 249 services; 2024 $21K for 272 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michelle V Lisgaris prescribed most often to Medicare patients was Symtuza (Darunavir/Cob/Emtri/Tenof Alaf), with 113 prescriptions and refills. In total Michelle V Lisgaris wrote 1,783 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 113 | 121 | 12 | $559K |
| Atorvastatin Calcium Generic | 99 | 151 | 17 | $705 |
| Tivicay Dolutegravir Sodium | 98 | 98 | Under 11 | $220K |
| Descovy Emtricitabine/Tenofov Alafenam | 58 | 58 | Under 11 | $121K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 58 | 58 | Under 11 | $240K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 56 | 64 | 18 | $1,985 |
| Amlodipine Besylate Generic | 49 | 79 | Under 11 | $221 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 49 | 49 | Under 11 | $11K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 48 | 48 | Under 11 | $185K |
| Prezcobix Darunavir/Cobicistat | 46 | 46 | Under 11 | $111K |
| Cefadroxil Generic | 42 | 77 | Under 11 | $1,251 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 41 | 41 | Under 11 | $151K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 37 | 62 | 13 | $454 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 28 | 32 | Under 11 | $631 |
| Vancomycin Hcl Generic | 28 | 30 | Under 11 | $3,783 |
Brand drugs: 632 claims; generic drugs: 1,151 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle V Lisgaris $366 ($366 in general payments such as food, travel and fees) from 6 companies. The largest payer was Gilead Sciences, Inc. with $188.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.